Databreach Impacts Business Operations at Sun Pharmaceutical
A ransomware group has claimed responsibility for 'IT security incident' at Sun Pharma whose effect included breach of certain file systems and the theft of certain company data and personal data, the drugmaker said in a stock exchange filing. "As part of the containment measures, we proactively isolated our network and initiated the recovery process. As a result of these measures, Company’s business operations have been impacted," it said. "Consequently, revenues are expected to be reduced in some of our businesses. The Company would incur expenses in connection with the incident and the remediation."
Sun Pharma first reported the incident on March 2. Back then it said that the incident did not affect Sun’s core systems and operations. On March 27 the company said it is currently unable to determine other potential adverse impacts of the incident.